Discerning Trends in Multiplex Immunoassay Technology with Potential for Resource-Limited Settings

Abstract

BACKGROUND In the search for more powerful tools for diagnoses of endemic diseases in resource-limited settings, we have been analyzing technologies with potential applicability. Increasingly, the process focuses on readily accessible bodily fluids combined with increasingly powerful multiplex capabilities to unambiguously diagnose a condition without resorting to reliance on a sophisticated reference laboratory. Although these technological advances may well have important implications for the sensitive and specific detection of disease, to date their clinical utility has not been demonstrated, especially in resource-limited settings. Furthermore, many emerging technological developments are in fields of physics or engineering, which are not readily available to or intelligible to clinicians or clinical laboratory scientists. CONTENT This review provides a look at technology trends that could have applicability to high-sensitivity multiplexed immunoassays in resource-limited settings. Various technologies are explained and assessed according to potential for reaching relevant limits of cost, sensitivity, and multiplex capability. Frequently, such work is reported in technical journals not normally read by clinical scientists, and the authors make enthusiastic claims for the potential of their technology while ignoring potential pitfalls. Thus it is important to draw attention to technical hurdles that authors may not be publicizing. SUMMARY Immunochromatographic assays, optical methods including those involving waveguides, electrochemical methods, magnetorestrictive methods, and field-effect transistor methods based on nanotubes, nanowires, and nanoribbons reveal possibilities as next-generation technologies.

Magnetoresistive performance and comparison of supermagnetic nanoparticles on giant magnetoresistive sensor-based detection system

“…Different kinds of ultra-sensitive biosensors have been designed and developed1234567. Chip-based detection of biological agents using giant magnetoresistive (GMR) sensors and magnetic labels have emerged recently8910111213141516, and this GMR sensing technology has the merits of low cost, portability, high sensitivity, and real-time electronic readout. In addition, the fabrication of GMR sensors is compatible with the current large-scale integration technologies, so GMR sensors can be easily integrated and their cost can be greatly reduced as mass production is carried out.…”

Tracing environmental markers of autoimmunity: introducing the infectome

“…IgM, IgA and IgG antibody infectious serology testing is likely to be the most common method of detecting organisms, but also the most economical and efficient. Multiplex immunoassays such as ELISA and indirect immunofluorescence for the detection of antibodies against infectious agents are relatively inexpensive and provide valid information [290][291][292]. Largescale multiplex technologies include protein microarrays and peptidome libraries, which are able to detect antibody responses to several hundred antigens [293][294][295].…”

Development of optical biosensor technologies for cardiac troponin recognition

“…This method can be used in affinity-based assay for the detection of a broad range of biological molecules, including proteins, small molecules, and nucleic acid. 70,71,72,73 An optomagnetic biosensor based on nanoparticles that are magnetically actuated and optically detected in a sample fluid has been proposed for troponin detection. 74,75 There are electromagnets placed above and below the cartridge that generate magnetic forces, and supermagnetic particles are controlled and accelerated by them.…”